GAVISCON NAUSEA
Identification of Gaviscon Nausea
| No description |
Google image searchProduct monograph
Active ingredient
dimenhydrinate, 50 MG
DIN: 02490528
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: OTC
Company: MEDTECH PRODUCTS INC
Date: 24-FEB-2020
ATC:
- R06 — ANTIHISTAMINES FOR SYSTEMIC USE (ATC, ATC/DDD, )
- R06A — ANTIHISTAMINES FOR SYSTEMIC USE (ATC, ATC/DDD)
- R06AA — Aminoalkyl ethers (ATC, ATC/DDD)
- R06AA11 — DIMENHYDRINATE (ATC/DDD)
Pharmaceutical standard: USP
